Lumentum (LITE) Stock Valuation: A Real Boom, Priced Above My Bull Case

Every stock screener shows Lumentum with a loss of $92.96 a share and no P/E ratio. The loss is real, and most of it is beside the point: $7.8 billion is a one-time, non-cash charge for converting debt into shares. The number that matters is the price. At $1,085.42 the shares trade at 49.8 times the $21.78 that analysts expect the company to earn in fiscal 2027, and the business has to deliver that and more.

At the October 2, 2026 close the shares trade 66.8% above my triangulated Base value of $651, a downside of 40.1%. The Bear value of $347 is 68.0% below the price and the Bull value of $982 is 9.5% below it, so even my optimistic case sits under today's quote. Confidence is grade C, which carries a required margin of safety (MOS) of 50%. That puts the maximum buy price at $325, and the shares would have to fall about 70% to reach it. The business is excellent. The price is a different matter.

Route: SF-15 Semiconductors and ecosystem, subtype FAB/IDM-like photonics, with SF-13 industrial manufacturing as a cross-check for utilization and capital spending. Economic classification: Quality Growth (7/12). Primary method: growth-adjusted EV/EBITDA on normalized fiscal 2027 EBITDA. Secondary method: ten-year free cash flow model. Cross-check: forward P/E. Lumentum's fiscal year ends in late June, so fiscal 2027 runs from July 2026 to June 2027. Values are present fair value estimates, not 12 month price targets.

What Lumentum is

Lumentum makes the lasers and optical parts that move data inside and between AI data centers: semiconductor laser chips, cloud transceivers, optical circuit switches (OCS, which steer light without converting it to electricity), external laser sources for co-packaged optics (CPO, which puts the optics next to the chip) and high-power lasers for industry. In the fourth quarter Components revenue was $649 million, up 103% year over year, and Systems revenue was $357 million, up 123%.

Two events changed the company in fiscal 2026. In March 2026 NVIDIA bought 2,876,415 shares of Series A convertible preferred stock at $695.31 each, $2.0 billion in total, alongside a non-exclusive multi-billion purchase commitment and future capacity access rights. The preferred converts into common stock one for one. Lumentum also bought a fab in Greensboro, North Carolina to add U.S. indium phosphide (InP, the material used for these lasers) capacity. On the May 2026 call management said revenue from that site was about six quarters away, so it is not in this year's numbers.

Concentration is the other side of the same story. One customer was 26.6% of fiscal 2026 revenue, up from 15.4% a year earlier, and a second was 15.0%. Together they were 41.6% of revenue against 31.4% the year before, and one customer holds 30.4% of receivables. About 79.2% of revenue comes from customers outside the United States.

The latest quarter

Q4 fiscal 2026 (quarter ended June 27, 2026)	Result
Revenue	$1,006.3 million, up 109.3% year over year and 24.5% from the third quarter
Gross margin	GAAP 47.4%, non-GAAP 50.4% (a year earlier: 33.3% GAAP)
Operating margin	GAAP 27.8%, non-GAAP 36.6% (first quarter of the year: 18.7% non-GAAP)
Earnings per share	GAAP net loss of $7.2 billion, or $84.65 a share, after a $7.8 billion loss on debt extinguishment. Non-GAAP $3.23 a share.
Full year	Revenue $3,014.0 million (+83.2%), non-GAAP net income $782.3 million ($8.67 a share), GAAP net loss $6.94 billion
Cash flow, full year	Operating cash flow $751.4 million, capital spending $451.3 million, stock-based compensation $170.2 million
Liquidity	Cash and short-term investments of $2.74 billion against debt principal of about $1.65 billion
First quarter fiscal 2027 outlook	Revenue $1.225 billion to $1.275 billion, non-GAAP operating margin 39.5% to 40.5%, non-GAAP EPS $4.05 to $4.35

The operating inflection is genuine, and management says why. It credits the fourth-quarter gross margin to better manufacturing utilization, favorable mix and higher prices on selected products. Utilization is the number to remember. It lifts margins quickly in an upcycle and takes them away just as quickly if installed capacity outruns demand.

Why GAAP earnings and headline cash flow cannot be used

Fiscal 2026 GAAP earnings are useless as an anchor, because the $7.8 billion debt extinguishment charge swamps the operating result. Headline cash flow is not much better. Operating cash flow of $751.4 million minus capital spending of $451.3 million gives free cash flow of $300.1 million. After deducting $170.2 million of stock-based compensation (SBC), a real cost paid in shares, the hard figure is $129.9 million, or 43.3% of the headline.

Fiscal year	Revenue	Free cash flow
2022	$1,713 million	$368 million
2023	$1,767 million	$51 million
2024	$1,359 million	-$108 million
2025	$1,645 million	-$105 million
2026	$3,014 million	$300 million

The five-year average free cash flow is only about $101 million, so one good year cannot simply be capitalized. Free cash flow for fiscal 2022 to 2025 comes from the framework analysis and I did not reopen those filings.

My normalized fiscal 2027 scenarios are EBITDA (earnings before interest, taxes, depreciation and amortization) of $2.10 billion in the Bear case, $2.56 billion in the Base case and $2.84 billion in the Bull case. The Bull figure is the third-party consensus of about $2.84 billion, and the Base applies a haircut of about 10% to it. Free cash flow in the same cases is $0.70 billion, $1.00 billion and $1.14 billion. For perspective, fiscal 2026 adjusted EBITDA was $1.03 billion. The first-quarter guidance alone implies about $500 million of operating income, and with depreciation my estimate is a run rate near $2.2 billion of EBITDA. The Bear case therefore sits slightly below today's run rate, the Base needs an average quarter about 19% above the first quarter, and the Bull needs one about 31% above it. Both consensus EBITDA and free cash flow add SBC back.

Balance sheet and shares

The balance sheet has changed. Cash and short-term investments of $2.74 billion less debt principal of about $1.65 billion leaves roughly $1.09 billion of net cash, helped by the $2.0 billion from NVIDIA. That is only about 1% of the fully diluted market value, so it does not change the valuation much.

The share count is where a screener misleads. The screen shows 89.7 million common shares as of August 14, 2026, up from 69.8 million a year earlier because Lumentum issued about 10.6 million shares in exchange for convertible notes during fiscal 2026. That is not the full picture. The NVIDIA preferred stock, outstanding employee awards and the remaining notes, which are deep in the money at $1,085.42, all belong in the denominator.

Convertible note (principal)	Conversion price	Underlying shares	Extra shares at $1,085.42
2032 notes ($1,265.0 million)	$187.77	6.74 million	5.57 million
2029 notes ($54.9 million)	$69.54	0.79 million	0.74 million
2028 notes ($179.6 million)	$131.03	1.37 million	1.21 million
2026 notes ($54.8 million)	$99.29	0.55 million	0.50 million
Total ($1,554.3 million)		9.45 million	8.02 million

The extra shares assume the principal is repaid in cash, which is why the notes stay in debt, and only the value above principal is paid in shares. The 2032 capped call (a purchased option that offsets dilution up to $268.24) is worth about $542 million above that price, equal to roughly 0.50 million shares. The fully diluted bridge is 89.70 million common, plus 2.88 million preferred, plus about 3.00 million employee awards, plus 8.02 million from the notes, minus 0.50 million for the capped call, which gives about 103.1 million economic shares. As a check, the company's own fourth-quarter non-GAAP net income of $326.3 million and $3.23 a share imply about 101.0 million diluted shares. I use 103.1 million for all per share values. Historical dilution is a red flag, and today's price makes the remaining notes expensive to ignore.

Primary valuation: growth-adjusted EV/EBITDA

Enterprise value (EV) is market value plus debt minus cash. I apply a multiple to normalized fiscal 2027 EBITDA and add net cash of $1.09 billion. The multiples are assumptions that sit well below what mechanically capitalizing 100% growth would justify: 20x in the Bear case, 27x in the Base and 34x in the Bull. I did not build them from a list of premiums and penalties, so the sensitivity grid below tests them.

Case	EBITDA	EV/EBITDA	Value per share
Bear	$2.10 billion	20x	$418
Base	$2.56 billion	27x	$681
Bull	$2.84 billion	34x	$947

Each value is EBITDA times the multiple, plus $1.09 billion of net cash, divided by 103.1 million shares. The primary Base is $681.

Sensitivity: value per share

EBITDA \ EV/EBITDA	22x	27x	32x
$2.20 billion	$480	$587	$693
$2.56 billion	$557	$681	$805
$2.84 billion	$617	$754	$892

No cell in the table reaches today's price. The most generous cell, full consensus EBITDA at 32x, gives $892.

Secondary valuation: ten-year free cash flow model

The secondary method is independent of the EBITDA multiple. It discounts ten years of free cash flow, with explicit forecasts for fiscal 2027 to 2029, then fading growth, then a terminal value, and adds the same net cash. The Bull case uses the published third-party consensus path for fiscal 2027 to 2029.

	Bear	Base	Bull
Free cash flow, fiscal 2027	$0.70 billion	$1.00 billion	$1.14 billion
Free cash flow, fiscal 2028	$1.30 billion	$2.00 billion	$2.51 billion
Free cash flow, fiscal 2029	$2.00 billion	$3.20 billion	$4.34 billion
Growth, years 4 to 10	15% fading to 4%	25% fading to 5%	30% fading to 6%
Discount rate / terminal growth	12.0% / 2.25%	10.5% / 2.75%	9.5% / 3.0%
Terminal value share of total	49%	59%	65%
Value per share	$248	$598	$1,056

The secondary Base is $598. Even the Bull case, which takes the consensus ramp at a 9.5% discount rate, lands slightly below the price. These free cash flow figures add SBC back, which the robustness table in the adversarial review adjusts for.

Sensitivity of the Base model: value per share

Discount rate \ terminal growth	2.0%	2.75%	3.5%
9.5%	$655	$701	$759
10.5%	$565	$598	$638
11.5%	$495	$519	$548

Historical cross-check and growth diagnostics

Lumentum's forward P/E has ranged from 11.8x in fiscal 2022 to 54.6x in fiscal 2024, with 25.9x in fiscal 2025 and 51.6x in fiscal 2026; the average of those five years is about 33x. These figures come from a public data provider cited in the framework analysis and I could not confirm them independently, so the check carries only a 20% weight. A normalized 30x on fiscal 2027 consensus EPS of $21.78 gives $653. For the scenarios, the Bear applies 20x to $16.00 (about the first-quarter guidance midpoint of $4.20 times four, less 5%), which gives $320, and the Bull applies 38x to $25.27, the top of the estimate range, which gives $960. Non-GAAP EPS leaves SBC out, so multiples quoted on it already reflect that convention.

The growth valuation cross-check (SM-19) is a diagnostic only. The forward P/E of 49.8x divided by expected EPS growth of about 151% gives a PEG of 0.33, which looks absurdly cheap and supports nothing. Fiscal 2027 growth is a mix of structural AI optics demand, higher utilization and a low prior-year base. Growth durability: structural and normalizing. Cyclical distortion: high. Lumentum trades at roughly a 39% premium to Coherent and 96% to Fabrinet on forward P/E, using screener figures that I could not reproduce and do not weigh. SM-19 does not set fair value.

The free cash flow growth quality check (SM-20) says the same thing from the cash side. Free cash flow of $300.1 million in fiscal 2026 would have to reach the consensus $4.34 billion in fiscal 2029, an increase of $4.04 billion and a compound growth rate of about 144% a year over three years. On 103.1 million shares that is $2.91 a share rising to $42.12. The implied free cash flow margin goes from 10.0% to roughly 31%, which depends on third-party revenue estimates that I could not verify. Measured on today's economic equity value of $111.9 billion, the free cash flow yield is 0.27% on fiscal 2026 (0.12% after SBC), 1.0% on fiscal 2027, 2.2% on fiscal 2028 and 3.9% on fiscal 2029. Even after three years of extreme growth, the yield is not obviously cheap. Distortion flags: low base high, cyclical rebound high, capital spending timing medium, working capital medium, dilution high. Estimate reliability: medium. Classification: structural with execution risk. The score is 56/100 and it is diagnostic only.

Fiscal 2029 free cash flow	Amount	Per share (103.1 million)	Three-year per share growth
Bear	$2.00 billion	$19.40	88% a year
Base	$3.20 billion	$31.04	120% a year
Bull / consensus	$4.34 billion	$42.12	144% a year

Even the Bear case compounds at 88% a year, which shows how much of the percentage growth is the low starting point.

Valuation triangulation

Method	Bear	Base	Bull	Weight
Primary EV/EBITDA	$418	$681	$947	50%
Ten-year free cash flow model	$248	$598	$1,056	30%
Forward P/E cross-check	$320	$653	$960	20%
Triangulated value	$347	$651	$982	100%

The primary and secondary Base values differ by 13.0%, under the 20% warning threshold. That agreement is weaker evidence than it looks, because both methods lean on the same consensus cash flow path. The P/E check gets the lowest weight because Lumentum's multiple has swung so widely with the cycle. The unrounded values are $347.35, $650.62 and $982.30.

What is the market already pricing in?

At $1,085.42 and 103.1 million economic shares, market value is about $111.9 billion and enterprise value about $110.8 billion. That is 43.3x my Base EBITDA, 39.0x consensus EBITDA and 108x fiscal 2026 adjusted EBITDA. At the Base multiple of 27x the price requires EBITDA of about $4.10 billion, 60% above my Base and 44% above the consensus. Even at the Bull multiple of 34x it needs $3.26 billion, more than my Bull EBITDA of $2.84 billion.

In cash flow terms, the price equals about 1.83 times my entire Base free cash flow path at a 10.5% discount rate, which would mean roughly $5.9 billion of free cash flow in fiscal 2029 instead of $3.2 billion. Alternatively, it equals the full consensus path with a discount rate of about 9.3% and 3% terminal growth. A buyer today needs six things to be true: AI optics growth is structural, Lumentum wins a large share of CPO, OCS and 1.6T demand, fiscal 2029 free cash flow reaches or beats consensus, margins stay far above the pre-2026 cycle, new capacity does not cause oversupply and customer concentration does not erode pricing. The market is not pricing a good outcome. It is pricing something near my best case.

Bear, base and bull scenarios

	Bear	Base	Bull
Main assumptions	Utilization normalizes faster than expected, CPO and OCS deployments slip, large customers push on price, multiple falls to 20x	Revenue very strong but below the top of consensus, margins stay above fiscal 2024 and 2025, CPO and OCS scale well but not perfectly, 27x	Fiscal 2027 consensus is met, fiscal 2029 free cash flow near $4.34 billion, capacity stays tight, 34x
Normalized EBITDA, fiscal 2027	$2.10 billion	$2.56 billion	$2.84 billion
Free cash flow, fiscal 2029	$2.00 billion	$3.20 billion	$4.34 billion
Value per share	$347	$651	$982
Versus $1,085.42	-68.0%	-40.1%	-9.5%

I assign no probabilities to the scenarios. The Bear is not a collapse: it keeps a 20x multiple because the secular AI optics story would still be intact. All three values sit below the price, and the price is reachable only if Lumentum beats my Bull case.

How the buy price is set

A Confidence C score carries a base MOS range of 35% to 50%, and I start at 40%. I add 5 points for operating leverage and cyclicality, 5 points for customer concentration and 5 points for convertible and valuation complexity, and subtract 5 points for the net cash balance sheet. The required MOS is 50%. Applied to the $651 Base, the maximum buy price is $325, and a stronger 60% margin marks a strong-buy reference near $260. Without the extra margin the maximum buy price would be $390. The shares would need to fall about 70% from $1,085.42 to reach $325.

Dividend and capital return

Lumentum pays no dividend, so the income check does not apply. Capital goes to capacity, research and strategic growth.

Reasons to own LITE

A genuine secular driver. Electrical links are running into limits inside AI systems, and optical content per system keeps rising.
Differentiated technology. InP lasers, ultra-high-power lasers, coherent components, VCSELs and OCS make this more than a single-product story.
External validation. NVIDIA's $2.0 billion investment, purchase commitment and capacity rights add demand visibility.
Operating leverage is visible. Non-GAAP operating margin rose from 18.7% to 36.6% in four quarters, and the guidance points to about 40%.
Several growth layers. 1.6T modules, CPO and external laser sources, scale-up connectivity and OCS, which had a backlog above $400 million in February.

What could go wrong?

Thesis breaker: consensus cash flow. The price needs extraordinary free cash flow growth. A material miss on fiscal 2027 to 2029 could compress the multiple severely even if revenue keeps growing.
Customer concentration. Two customers are 41.6% of revenue. A design loss, a deployment delay, an inventory correction or a price negotiation at one of them changes the growth path.
Capacity and cycle. Net property and equipment rose to $1.16 billion from $726 million and inventory rose 47% to $692 million. If demand normalizes after the capacity is installed, utilization and margins can reverse quickly.
Dilution and capital structure. Shares rose 28% in a year, and the remaining notes, the NVIDIA preferred stock and employee awards add about 13 million shares more.
Technology and competition. CPO, NPO, VCSEL, silicon photonics and other suppliers can change customer choices and market share.
Export controls and geopolitics. About 79% of revenue is shipped outside the United States.

Management execution

Michael Hurlston became chief executive in February 2025, after senior roles at Synaptics, Finisar and Broadcom. Since then, Lumentum has met or beaten its revenue guidance quarter after quarter, reached its target revenue model earlier than planned, lifted gross margin sharply and secured the NVIDIA agreement. The offsets are a short record under this chief executive, a capital structure that produced extraordinary dilution and accounting complexity in fiscal 2026, and expectations that are now so high that good execution may not be enough. Assessment: 17/20, good to very good. The next test is whether margins hold as the new capacity comes online.

Stock Analyza scorecard

Economic classification	Score
Normalized return on invested capital	0/2
Revenue growth, multi-year	2/2
Free cash flow per share growth	0/2
Balance sheet	1/1
Unit economics	1/1
Recurring and repeat economics	1/2
Reinvestment runway	2/2
Total: Quality Growth	7/12

Compounder status is withheld because free cash flow per share has not compounded through a full cycle, free cash flow was negative in fiscal 2024 and 2025, customer concentration is high and part of the growth is a rebound from a low base. Business quality is 74/100: moat and pricing power 16/20, return versus cost of capital 12/20, balance sheet 12/15, earnings and cash quality 9/15, growth and runway 15/15, management and capital allocation 8/10, dilution and governance 2/5. The valuation score is 18/100: discount to Base 0/40, protection against the Bear case 0/20, agreement between methods 12/15, historical valuation 3/10, reverse valuation 0/10, data and model quality 3/5.

Confidence score

Confidence	Score
Data quality / source provenance	4/5
Predictability	2/5
Valuation robustness	2/5
Accounting transparency	3/5
Scenario dispersion	2/5
Total	13/25, grade C

Historical reporting is strong. The grade is held down by uncertainty about future cash flow, a very wide range between Bear and Bull, customer concentration and the convertible notes.

What I would watch from here

Green

Quarterly revenue at or above $1.25 billion, guidance held or raised
Non-GAAP operating margin at or above 35%
Fiscal 2027 free cash flow at or above $1.0 billion
Free cash flow margin at or above 15% going forward
Largest customer below 30% of revenue
Inventory growing slower than revenue
Economic shares at or below 104 million
OCS and CPO deliveries on time, with new wins

Yellow

Quarterly revenue $1.15 billion to $1.25 billion
Non-GAAP operating margin 28% to 35%
Fiscal 2027 free cash flow $0.6 billion to $1.0 billion
Free cash flow margin 10% to 15%
Largest customer 30% to 40% of revenue
Inventory growing as fast as revenue
Economic shares 104 million to 110 million
Modest delays in OCS or CPO, utilization flat

Red

Quarterly revenue below $1.15 billion, or a material guidance cut
Non-GAAP operating margin below 28%
Fiscal 2027 free cash flow below $0.6 billion
Free cash flow margin below 10% after the scale-up
Largest customer above 40% of revenue
Inventory materially outgrowing revenue
Economic shares above 110 million without matching value creation
Cancellations, deployment delays, or more capacity with falling utilization, or a cut of more than 20% to fiscal 2028 and 2029 free cash flow estimates

Today's readings are green on non-GAAP operating margin (36.6%), the largest customer (26.6%), inventory growth (47% against revenue growth of 83%) and economic shares (about 103.1 million). Free cash flow margin is 10.0% for fiscal 2026, at the edge of the red zone before the scale-up, and the two largest customers together are 41.6% of revenue. The next review point is the first-quarter fiscal 2027 report, expected in early November 2026 (the date I have, November 3, is an estimate).

The three most important thesis breakers

Estimates for fiscal 2027 to 2029 free cash flow are cut materially.
Gross and operating margins fall while capacity rises.
A major hyperscaler or customer reduces orders or changes its architecture or supplier.

Adversarial review

I recomputed the share bridge, scenario values, both sensitivity grids, the triangulation, the margin of safety and the yields independently, and checked the reported inputs against the 10-K, the fourth-quarter release, the NVIDIA filing and the market price. The reconciliation was mostly clean. The corrections came in rounding, per share consistency, the score breakdown and a few statements.

Item	First draft	Corrected
Bear, Base and Bull values	$350, $650 and $980, rounded from $347.35, $650.62 and $982.30	$347, $651 and $982, without the rounding. The draft's percentages already used the unrounded values.
Valuation score	18/100 with no breakdown	Rebuilt from six components, which also gives 18/100
Free cash flow per share	Mixed share counts of 103.1, 105 and about 104 million	One count of 103.1 million. Fiscal 2029 consensus: $41.36 to $42.12 and 142% to 144%. Bear: $19.2 and 86% to $19.40 and 88%. Base: $31.4 and 119% to $31.04 and 120%.
Stock-based compensation	Called free cash flow after SBC the hardest metric, but valued on consensus EBITDA and free cash flow that add it back	Base kept, because employee awards are already in the share count. Effect shown in the robustness table.
Greensboro fab timing	Ramp expected in mid-2028	Management said in May 2026 that revenue was about six quarters away
Bear case reachability	Not tested	The Bear EBITDA of $2.10 billion sits below the first-quarter run rate of about $2.2 billion. It is reachable, but it is a decline from here.
Multiples of 20x, 27x and 34x	Presented as a rationale without a build	Labeled as assumptions and tested in the grid
Peer P/E and historical P/E	Stated as fact	Labeled as screener figures that I could not reproduce, with no weight in the Base

None of these corrections changes the Reduce verdict, the 50% margin of safety or the $325 maximum buy price.

The strongest counter-thesis, for the bulls: optical content in AI infrastructure is entering a multi-year nonlinear phase, Lumentum becomes a constrained supplier of high-power lasers and OCS, fiscal 2029 free cash flow reaches $4.3 billion or more, and the market keeps paying a premium because CPO and scale-up connectivity make optical demand recurring. Under the full consensus path and a 9.5% discount rate the model gives $1,056, and at 9.0% it gives about $1,158. The response is that this is possible and sits in my Bull case, but today's price already requires something close to it, so the Base case offers no margin of safety.

Robustness check	Value per share
Base free cash flow model	$598
Base free cash flow model, entire path 20% lower	$481
Base free cash flow model, entire path 40% lower	$363
Full consensus path, 9.5% discount rate and 3.0% terminal growth	$1,056
Full consensus path, 9.0% discount rate and 3.0% terminal growth	$1,158
Primary Base at 22x and at 32x (EBITDA $2.56 billion)	$557 and $805
Primary Base using only the 89.7 million common shares	$783, 15% higher than with the full bridge
Primary Base after estimated SBC of $230 million in fiscal 2027	$621
Free cash flow model after estimated SBC ($230 million, $290 million and $350 million, then growing 6% a year)	$551
Triangulated Base after SBC (maximum buy price $303)	$606
Forward P/E check, 30x fiscal 2027 EPS	$653
Required margin of safety of 40% instead of 50%	Maximum buy price $390

Audit flags: the SBC path is my estimate, built from $170.2 million in fiscal 2026, and it partly overlaps with the awards already counted in the share bridge, so it is a stress test, not a replacement for the Base. Consensus EBITDA, free cash flow, EPS and the implied revenue behind the margins come from third-party datasets that I could not reproduce from free sources. The older free cash flow history and the forward P/E history come from the framework analysis. Finance lease liabilities are not separated in the net cash figure. I did not compute return on invested capital from audited invested capital, so the 12/20 return score reflects the trend, not a measured through-cycle return above the cost of capital. The convertible settlement mix is unknown. The publication gate status is PASS WITH WARNING because future cash flow estimates are unusually aggressive and the capital structure contains material conversion uncertainty.

Final verdict: reduce at $1,085.42

Lumentum is a high-quality AI optics business whose fundamentals have changed dramatically. The shares, though, now trade above my Bull value, and the price needs the full consensus cash flow path plus a low discount rate. The 2032 convertible notes carry a conversion price of $187.77, so the holders who bought them paid for the right to own the company at that level. A buyer of the shares today pays 5.8 times as much.

Verdict: REDUCE at $1,085.42. Triangulated Base value $651, downside 40.1%, Confidence C (13/25). Required margin of safety 50%, maximum buy price $325.

The main risk to this verdict is that the AI optics opportunity proves much larger and more durable than my Base, so that fiscal 2029 free cash flow reaches $4.3 billion or more with margins and multiples intact. New money belongs on the watchlist until the price approaches $325.

Sources

Primary sources include Lumentum's Form 10-K for the fiscal year ended June 27, 2026, the fourth-quarter and full-year release of August 11, 2026, the Form 8-K on the NVIDIA preferred stock and the quarterly releases and calls for fiscal 2026. The October 2, 2026 close of $1,085.42 and the share count come from StockAnalysis. Consensus estimates and multiples come from public aggregators cited in the framework analysis (StockAnalysis, MarketScreener) and are labeled as estimates.

The reference market price is the October 2, 2026 regular session close at 4:00 PM EDT. Balance sheet and cash flow figures are as of June 27, 2026, and the common share count is as of August 14, 2026. The economic share count, normalized EBITDA, scenario values and the SBC stress test are analytical estimates, not company guidance.